Tumor hypoxia: From basic knowledge to therapeutic implications

• Published in: Seminars in cancer biology Vol. 88; pp. 172 - 186
• Main Authors: Liao, Chengheng, Liu, Xijuan, Zhang, Cheng, Zhang, Qing
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.01.2023
• Subjects: Angiogenesis; Carcinogenesis; Cell Hypoxia; Humans; Hypoxia; Hypoxia-inducible factors; Immunotherapy; Metabolism; Neoplasms - drug therapy; Neoplasms - therapy; Tumor Hypoxia; Tumor microenvironment; Tumor Microenvironment - genetics; Hypoxia-inducible factors; Angiogenesis; Hypoxia; Tumor microenvironment; Metabolism; Immunotherapy
• ISSN: 1044-579X; 1096-3650; 1096-3650
• DOI: 10.1016/j.semcancer.2022.12.011

Diminished oxygen availability, termed hypoxia, within solid tumors is one of the most common characteristics of cancer. Hypoxia shapes the landscape of the tumor microenvironment (TME) into a pro-tumorigenic and pro-metastatic niche through arrays of pathological alterations such as abnormal vasculature, altered metabolism, immune-suppressive phenotype, etc. In addition, emerging evidence suggests that limited efficacy or the development of resistance towards antitumor therapy may be largely due to the hypoxic TME. This review will focus on summarizing the knowledge about the molecular machinery that mediates the hypoxic cellular responses and adaptations, as well as highlighting the effects and consequences of hypoxia, especially for angiogenesis regulation, cellular metabolism alteration, and immunosuppressive response within the TME. We also outline the current advances in novel therapeutic implications through targeting hypoxia in TME. A deep understanding of the basics and the role of hypoxia in the tumor will help develop better therapeutic avenues in cancer treatment.